The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma

Karabork A., KAYGUSUZ G., Ekinci C.

Pathology Research and Practice, cilt.206, sa.8, ss.572-577, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 206 Sayı: 8
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1016/j.prp.2010.03.004
  • Dergi Adı: Pathology Research and Practice
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.572-577
  • Anahtar Kelimeler: Hepatocellular carcinoma, Metastatic adenocarcinoma, Immunohistochemistry, Differential diagnosis, NEEDLE-ASPIRATION BIOPSIES, TRANSCRIPTION FACTOR-I, TISSUE ARRAY TECHNIQUE, RENAL-CELL CARCINOMA, CARCINOEMBRYONIC ANTIGEN, DIAGNOSTIC UTILITY, HEPATOCYTE ANTIGEN, HEP PAR-1, LIVER, CD10
  • Ankara Üniversitesi Adresli: Evet

Özet

It can be difficult to differentiate hepatocellular carcinoma (HCC) from metastatic adenocarcinoma (MA). An appropriate immunohistochemical panel is required for the differential diagnosis. This study aimed at finding the best panel, including hepatocyte-specific antigen (Hepatocyte), pCEA, CD10, Villin, CD34, TTF-1, MOC-31, CK7, and CK20 antibodies. Sixty-eight cases of HCC and 107 cases of MA were investigated. Hepatocyte positivity was seen in 95.6% of HCCs and in 1.9% of MAs. pCEA was expressed in 47.8% of HCCs and in 86.8% of MAs. CD10 stained 73.13% of HCCs and 36.9% of MAs. Villin was positive in 23.5% of HCCs and in 81.0% of MAs. Canalicular staining with pCEA, CD10, and Villin was seen only in HCCs. Sinusoidal CD34 staining was seen only in 42.6% of HCCs. A small subset of HCCs demonstrated cytoplasmic TTF-1 and MOC-31. CK7 was expressed in 29.4% of HCCs and in 29.9% of MAs, whereas CK20 stained 14.7% of HCCs and 62.6% of MAs. In conclusion, Hepatocyte should be combined with pCEA, MOC-31, CD10, and CD34. Canalicular staining with pCEA, CD10, and Villin is specific for HCC. CK7 and CK20 expression may be seen in some HCCs. We suggest that the best panel for discriminating HCC from MA should contain Hepatocyte, MOC-31, pCEA, CD10, and CD34. © 2010 Elsevier GmbH.